MyFinsight
Home
Blog
About
Contact
Back
Income Statement
NewAmsterdam Pharma Co N.V. (NAMSW)
NewAmsterdam Pharma Co N.V. (NAMSW)
source: myfinsight.com
Download
Download image
Total comprehensive
gain for the year, net...
-$49,013K
Gain for the year
-$48,441K
Unrealized loss/(gain) on
available-for-sale securities, net...
-$572K
Gain before tax
-$48,441K
Fair value change -
warrants
-$5,942K
Interest income
$5,650K
Supply revenue
$3,040K
Operating loss
-$58,420K
Revenue
$3,040K
Foreign exchange
gains/(losses)
-$1,613K
Total operating
expenses
$61,460K
Research and development
expenses
$38,009K
Selling, general and
administrative expenses
$23,451K
Back